- Home
- INDV vs DOCS Comparison
INDV vs DOCS Comparison
Compare INDV & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | DOCS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.6B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INDV | DOCS |
|---|---|---|
| Price | $41.18 | $22.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 22 |
| Target Price | N/A | ★ $45.50 |
| AVG Volume (30 Days) | 1.6M | ★ 3.3M |
| Earning Date | 06-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | 0.69 | ★ 0.98 |
| Revenue | ★ $1,239,000,000.00 | $644,863,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | N/A | $8.83 |
| P/E Ratio | $57.96 | ★ $23.34 |
| Revenue Growth | 4.29 | ★ 13.05 |
| 52 Week Low | $15.00 | $17.15 |
| 52 Week High | $42.81 | $76.51 |
Technical Indicators
Market Signals| Indicator | INDV | DOCS |
|---|---|---|
| Relative Strength Index (RSI) | 63.02 | 61.39 |
| Support Level | $35.36 | $19.60 |
| Resistance Level | $42.81 | $25.53 |
| Average True Range (ATR) | 1.50 | 0.89 |
| MACD | -0.00 | 0.35 |
| Stochastic Oscillator | 67.31 | 77.75 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.